Encouraging Interim Data from a Phase 1 Clinical Study Evaluating MOv18 IgE in Cancer Patients with Advanced Solid Tumours Presented at the AACR Virtual Annual Meeting
April 27, 2020
MOv18 IgE is the first therapeutic IgE antibody to enter clinical trials Results support, for the first time, the safety and potential efficacy of an